The leading gene and cell therapies practitioners and consultants will share insights, technical and regulatory requirements, and expectations on successfully achieving and scaling-up robust, cost- and quality-efficient products, process developments, and manufacturing, as well as explore recent developments, emerging technologies, methods, and tools.